Kalos Management’s Organon & Co OGN Stock Holding History

Kalos Management’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-60	Closed	-$1.41K	–	295
2023 Q1	$1.41K	Buy	+60	New	+$1.61K	﹤0.01%	362

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Kalos Management's OGN Position: Q2 2023 in Review

Kalos Management sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 60 shares — an estimated $1.41K sold.

Kalos Management first reported a position in OGN in Q1 2023 and held it in 1 quarter. The position peaked at $1.41K in Q1 2023. 727 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

Kalos Management reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
Kalos Management sold 60 Organon & Co shares in Q2 2023, an estimated $1.41K.
Kalos Management first reported a position in Organon & Co in Q1 2023 and held it in 1 quarter.
Kalos Management's Organon & Co position peaked at $1.41K in Q1 2023.
727 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on Kalos Management's 13F filing for Q2 2023, filed 9 Aug 2023.